NYSE:MTNB

Matinas Biopharma Holdings Stock Insider Trading

etoro logo Buy MTNB
*Your capital is at risk
$0.294
-0.0236 (-7.44%)
At Close: Jul 31, 2026

Matinas Biopharma Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 80.16M and sold 0 MTNB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 80.16M shares
Sell 0 shares
100% Buy Activity
Moderate Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Dec 20, 2022
Buy
Stock Option (right to Buy)
A-Award
Liu Hui
Chief Technology Officer
Officer 625 000
Value: $0
Dec 20, 2022
Buy
Stock Option (right to Buy)
A-Award
Kucinski Keith A
Chief Financial Officer
C-Suite Officer 625 000
Value: $0
Dec 20, 2022
Buy
Stock Option (right to Buy)
A-Award
Jabbour Jerome D
President And CEO
CEO / President 1 988 300
Value: $0
Dec 20, 2022
Buy
Stock Option (right to Buy)
A-Award
Hoover Thomas
Chief Business Officer
Officer 475 000
Value: $0
Dec 20, 2022
Buy
Stock Option (right to Buy)
A-Award
Ferguson James J. Iii
Chief Medical Officer
Officer 625 000
Value: $0
Dec 20, 2022
Buy
Stock Option (right to Buy)
A-Award
Ferguson James J. Iii
Chief Medical Officer
Officer 625 000
Value: $0
Dec 20, 2022
Buy
Stock Option (right to Buy)
A-Award
Hoover Thomas
Chief Business Officer
Officer 475 000
Value: $0
Dec 20, 2022
Buy
Stock Option (right to Buy)
A-Award
Jabbour Jerome D
President And CEO
CEO / President 1 988 300
Value: $0
Dec 20, 2022
Buy
Stock Option (right to Buy)
A-Award
Kucinski Keith A
Chief Financial Officer
C-Suite Officer 625 000
Value: $0
Dec 20, 2022
Buy
Stock Option (right to Buy)
A-Award
Liu Hui
Chief Technology Officer
Officer 625 000
Value: $0
Dec 20, 2022
Buy
Stock Option (right to Buy)
A-Award
Matkovits Theresa
Chief Development Officer
Officer 625 000
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Giordano Natasha
Director
Director 142 657
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Corzo Kathryn Penkus
Director
Director 142 657
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Conrad Herbert J
Director
Director 142 657
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Wikler Matthew
Director
Director 142 657
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Ende Eric J
Director
Director 142 657
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Scibetta James S
Director
Director 142 657
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Scibetta James S
Director
Director 142 657
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Ende Eric J
Director
Director 142 657
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Wikler Matthew
Director
Director 142 657
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Conrad Herbert J
Director
Director 142 657
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Corzo Kathryn Penkus
Director
Director 142 657
Value: $0
Nov 14, 2022
Buy
Stock option (right to buy)
A-Award
Giordano Natasha
Director
Director 142 657
Value: $0
Jun 22, 2022
Buy
Common Stock, par value $0.0001 per share
G-Gift
Conrad Herbert J
Director
Director 1 358 122
Value: $0
Aug 04, 2021
Buy
Common Stock, par value $0.0001 per share
G-Gift
Conrad Herbert J
Director
Director 494 622
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MATINAS BIOPHARMA HOLDINGS INC
Matinas Biopharma Holdings
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a presc...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE